Last reviewed · How we verify
CXB722
At a glance
| Generic name | CXB722 |
|---|---|
| Also known as | Pivagabine |
| Sponsor | CeNeRx BioPharma Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CXB722 CI brief — competitive landscape report
- CXB722 updates RSS · CI watch RSS
- CeNeRx BioPharma Inc. portfolio CI